Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02753075 · ClinicalTrials.gov registry record · NA
A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.
A NA study of Dentin Sensitivity, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT02753075: Completed NA study of Dentin Sensitivity, sponsored by GlaxoSmithKline.
NCT02753075 is a NA study of Dentin Sensitivity that has completed, run by GlaxoSmithKline. The registered enrollment target is 240 participants, above the 197-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02753075, a NA study of Dentin Sensitivity, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the longitudinal efficacy of two experimental oral rinses, one containing 1.5% weight/weight (w/w) dipotassium oxalate monohydride (KOX) /0 Parts per Million (ppm fluoride) and the other 2.0% w/w KOX /45ppm fluoride, for the relief of dentinal hypersensitivity (DH), compared to a placebo oral rinse, when used as an adjunct to twice daily brushing with a standard fluoride toothpaste.
Primary Outcome
The examiner assessed the participant's response to an evaporative air stimulus for each selected two teeth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulu
Conditions Studied
Interventions
- DEVICE Experimental Oral Rinse 1
- DEVICE Experimental Oral Rinse 2
- OTHER Placebo Oral Rinse
- DRUG Fluoride toothpaste
Study Locations (1)
Indiana
- GSK Investigational Site - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2015-09-08 |
| Est. Completion | 2015-12-18 |
| Phase | NA |
What the finished NCT02753075 record still lists
NCT02753075 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 197-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (22% higher).
The record links to 1 condition, with Dentin Sensitivity appearing as the primary indexed condition, and to 4 interventions - of which Experimental Oral Rinse 1 is the first listed.
NCT02753075 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT02753075 about?
NCT02753075 is a clinical study titled "A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.". This study will investigate the longitudinal efficacy of two experimental oral rinses, one containing 1.5% weight/weight (w/w) dipotassium oxalate monohydride (KOX) /0 Parts per Million (ppm fluoride) and the other 2.0% w/w KOX /45ppm fluoride, for the relief of dentinal hypersensitivity (DH), compa...
What is the current status of trial NCT02753075?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2015-09-08. Estimated completion is 2015-12-18.
What conditions does trial NCT02753075 study?
This clinical trial studies the following conditions: Dentin Sensitivity.
What interventions are being tested in trial NCT02753075?
The interventions under investigation include: Experimental Oral Rinse 1 (DEVICE), Experimental Oral Rinse 2 (DEVICE), Placebo Oral Rinse (OTHER), Fluoride toothpaste (DRUG).
Who is sponsoring clinical trial NCT02753075?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02753075 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dentin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief
RECRUITING · NA
-
A Pilot Study to Assess Nominal Versus Controlled Stimuli on Dentinal Hypersensitivity
COMPLETED · NA
-
Effectiveness of Two Water-Based Potassium Oxalate Desensitizers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI